Jeppson Wealth Management’s Antares Pharma, Inc. ATRS Stock Holding History

Jeppson Wealth Management’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-55,235	Closed	-$226K	–	204
2022 Q1	$226K	Sell	55,235 -1,300	-2%	-$4.72K	0.11%	156
2021 Q4	$202K	Buy	56,535 +5,490	+11%	+$19.2K	0.1%	152
2021 Q3	$185K	Hold	51,045	–	–	0.1%	149
2021 Q2	$222K	Sell	51,045 -150	-0.3%	-$611	0.12%	134
2021 Q1	$210K	Sell	51,195 -1,300	-2%	-$5.63K	0.12%	132
2020 Q4	$209K	Buy	52,495 +4,400	+9%	+$14.2K	0.14%	129
2020 Q3	$130K	Buy	+48,095	New	+$133K	0.1%	151

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Jeppson Wealth Management's ATRS Position: Q2 2022 in Review

Jeppson Wealth Management sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 55,235 shares — an estimated $226K sold.

Jeppson Wealth Management first reported a position in ATRS in Q3 2020 and held it in 7 quarters. The position peaked at $226K in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Jeppson Wealth Management reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Jeppson Wealth Management sold 55,235 Antares Pharma, Inc. shares in Q2 2022, an estimated $226K.
Jeppson Wealth Management first reported a position in Antares Pharma, Inc. in Q3 2020 and held it in 7 quarters.
Jeppson Wealth Management's Antares Pharma, Inc. position peaked at $226K in Q1 2022.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Jeppson Wealth Management's 13F filing for Q2 2022, filed 3 Aug 2022.